AGAMMAGLOBULINAEMIE UND SEKRETORISCHES IGA. = L'AGAMMAGLOBULINEMIE ET L'IGA SECRETOIRETYMPNER KD; SCHLIMOK G; ROTH H et al.1977; KLIN. PAEDIATR.; DTSCH.; DA. 1977; VOL. 189; NO 4; PP. 269-276; ABS. ANGL.; BIBL. 14 REF.Article

Lymphozytensubpopulationen ― und HLA-DR-Bestimmungen bei Erkrankungen des Innenohres und Bellschen Paresen = Déterminations des sous-populations de lymphocytes et de HLA-DR dans les maladies de l'oreille interne et la paralysie de Bell = Lymphocyte subpopulations and HLA-DR system in inner car diseases and Bell's palsyBUMM, P; SCHLIMOK, G.HNO. Hals-, Nasen-, Ohrenärzte. 1986, Vol 34, Num 12, pp 525-527, issn 0017-6192Article

DER IGA-LATEX-TEST. EIN SCHNELLES VERFAHREN ZUM IGA-NACHWEIS = LE TEST IGA-LATEX. UNE METHODE RAPIDE POUR LA MISE EN EVIDENCE IGASCHLIMOK G; NEUHAUS F; WELSCH H et al.1974; KLIN. PAEDIATR.; DTSCH.; DA. 1974; VOL. 186; NO 6; PP. 529-534; ABS. ANGL.; BIBL. 13REF.Article

Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridizationMÜLLER, P; WECKERMANN, D; RIETHMÜLLER, G et al.Cancer genetics and cytogenetics. 1996, Vol 88, Num 1, pp 8-16, issn 0165-4608Article

SUBTYPES OF T-CELL CHRONIC LYMPHATIC LEUKEMIA = SOUS-TYPES DE LEUCEMIE LYMPHOCYTAIRE CHRONIQUE A CELLULES THUHN D; THIEL E; RODT H et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 8; PP. 1434-1447; ABS. ENG; BIBL. 43 REF.; GRAPH, FIGArticle

PROLIFERATION OF T-LYMPHOCYTES IN TWO PATIENTS: CLINICAL FEATURES AND FUNCTIONAL PROPERTIES OF THE PROLIFERATING CELLSSCHLIMOK G; THIEL E; RIEBER EP et al.1982; KLIN. WOCHENSCHR.; ISSN 0023-2173; DEU; DA. 1982; VOL. 60; NO 3; PP. 133-142; ABS. GER; BIBL. 49 REF.Article

T-Lymphozytensubpopulationen und HLA-DR-Antigene beim Hörsturz, der Neuropathia vestibularis, dem Morbus Ménière un der Ballschen Parese = T-lymphocyte subpopulations and HLA-DR antigenes in patients with hearing loss, neuronitis vestibularis, Ménière's disease and Bell's palsyBUMM, P; MUÊLLER, E. C; GRIMM-MUÊLLER, U et al.Laryngo-, Rhino-, Otologie. 1991, Vol 70, Num 5, pp 260-266, issn 0935-8943, 7 p.Article

Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patientsLINDEMANN, F; SCHLIMOK, G; DIRSCHEDL, P et al.Lancet (British edition). 1992, Vol 340, Num 8821, pp 685-689, issn 0140-6736Article

Micrometastases of bone marrow in localized prostate cancer : Correlation with established risk factorsWECKERMANN, D; MÜLLER, P; WAWROSCHEK, F et al.Journal of clinical oncology. 1999, Vol 17, Num 11, pp 3438-3443, issn 0732-183XArticle

Guidelines for anti-emetic therapy : Acute emesisFAUSER, A. A; FELLHAUER, M; HOFFMANN, M et al.European journal of cancer (1990). 1999, Vol 35, Num 3, pp 361-370, issn 0959-8049Article

Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significanceSCHLIMOK, G; FUNKE, I; PANTEL, K et al.European journal of cancer (1990). 1991, Vol 27, Num 11, pp 1461-1465, issn 0959-8049Article

A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cellsFLIEGER, D; GRUBER, R; SCHLIMOK, G et al.Journal of immunological methods. 1995, Vol 180, Num 1, pp 1-13, issn 0022-1759Article

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cellsPANTEL, K; SCHLIMOK, G; BRAUN, S et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 17, pp 1419-1424, issn 0027-8874Article

Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19HÖCHTLEN VOLLMAR, W; GRUBER, R; BODENMÜLLER, H et al.International journal of cancer. 1997, Vol 70, Num 4, pp 396-400, issn 0020-7136Article

Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cellsPANTEL, K; SCHLIMOK, G; KUTTER, D et al.Cancer research (Baltimore). 1991, Vol 51, Num 17, pp 4712-4715, issn 0008-5472Article

Treatment results of the thioether lipid ilmofosine in patients with malignant tumoursWINKELMANN, M; EBELING, K; STROHMEYER, G et al.Journal of cancer research and clinical oncology. 1992, Vol 118, Num 6, pp 405-407, issn 0171-5216Article

Monoclonal antibody therapy for resected Dukes' C colorectal cancer : Seven-year outcome of a multicenter randomized trialRIETHMÜLLER, G; HOLZ, E; BUGGISCH, P et al.Journal of clinical oncology. 1998, Vol 16, Num 5, pp 1788-1794, issn 0732-183XArticle

Consolidation therapy with high-dose cytosine arabinoside : experiences of a prospective study in acute myeloid leukemiaKURRLE, E; EHNINGER, G; ÖHL, S et al.Haematology and blood transfusion. 1990, Vol 33, pp 254-260, issn 0171-7111Article

Mitoxantrone, cytosine arabinoside, and VP-16 in 36 patients with relapsed and refractory acute myeloid leukemiaLINK, H; FREUND, M; CALAVREZOS, A et al.Haematology and blood transfusion. 1990, Vol 33, pp 322-325, issn 0171-7111Article

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II studyBRUGGER, W; HIRSCH, J; KAUFMANN, M et al.Annals of oncology. 2004, Vol 15, Num 11, pp 1691-1698, issn 0923-7534, 8 p.Article

Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodiesSCHLIMOK, G; FUNKE, I; RIETHMÜLLER, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 23, pp 8672-8676, issn 0027-8424Article

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerBRAUN, S; PANTEL, K; RIETHMOLLER, G et al.The New England journal of medicine. 2000, Vol 342, Num 8, pp 525-533, issn 0028-4793Article

Detection of karyotypic aberrations in acute myeloblastic leukaemia : a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AMLKRAUTER, J; PETER, W; PORT, M et al.British journal of haematology. 1998, Vol 103, Num 1, pp 72-78, issn 0007-1048Article

Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemiaEHNINGER, G; FACKLER-SCHWALBE, E; MITROU, P. S et al.Haematology and blood transfusion. 1990, Vol 33, pp 316-317, issn 0171-7111Article

A multicentre study on intensive induction and consolidation therapy in acute myelogeneous leukaemiaKURRLE, E; EHNINGER, G; WANDT, H et al.Blut. 1988, Vol 56, Num 5, pp 233-236, issn 0006-5242Article